ArticleJournal of chemical ecology2026
Behavioral and Exumbrellar Integumental Defenses in Jellyfish: The Hydromedusan Spirocodon saltatrix Releases Oxidized Derivatives of Unsaturated Fatty Acids Potentially to Avoid Predation and Bacterial Biofouling.
Article in Journal of chemical ecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cnidarian jellyfish-the medusa phase of medusozoans-are gaining recognition as important prey for a variety of predators in marine trophic webs. However, their traits as prey remain poorly understood. In this study, we examined the defensive traits of jellyfish, focusing specifically on cnidocyte-independent chemical defenses that serve as strategies against consumers, pathogens, and biofouling. To investigate these anti-consumer chemical defenses, we selected three sympatric jellyfish species: the hydromedusan Spirocodon saltatrix and the scyphomedusan moon jellyfish Aurelia coerulea as prey, and the scyphomedusan Japanese sea nettle Chrysaora pacifica as the predator. Using these species, we conducted feeding experiments, ablation of potential defensive organs, and analyses of compounds released by the prey. We found that: (1) in feeding experiments, S. saltatrix individuals exhibited an involution behavior, in which they strongly contracted and retracted their tentacles inside the umbrella when captured by C. pacifica, thereby escaping, whereas A. coerulea individuals were consumed without escaping; (2) a series of surgical ablation experiments indicated that the umbrella integument of S. saltatrix possesses a defensive function; (3) gas chromatography-mass spectrometry (GC-MS) analyses showed that S. saltatrix releases C8 to C9 alcohols and aldehydes when its integument is damaged; (4) behavioral experiments demonstrated that these compounds deter feeding by the predatory jellyfish; (5) these compounds inhibited biofilm formation by the sympatric bacterium Ectopseudomonas sp. isolated from sediment, indicating their antifouling role, though their effects on planktonic biofouling remain to be tested; and (6) the experimentally determined effective concentrations were higher than the bulk measured concentrations. Therefore, we hypothesize that the natural microscale concentrations of these compounds at the injured integument are sufficiently high to match the effective thresholds, suggesting that they function as defensive agents. Thus, our study demonstrates that S. saltatrix utilizes involution behavior and its integument to avoid predation. To our knowledge, this is the first report of exumbrellar integumental defense in a cnidarian jellyfish with suggestive evidence of chemical defense using oxidized derivatives of unsaturated fatty acids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.